EvidenceNOW SW Learning Collaborative. Kyle Knierim, MD January 2017

Size: px
Start display at page:

Download "EvidenceNOW SW Learning Collaborative. Kyle Knierim, MD January 2017"

Transcription

1 EvidenceNOW SW Learning Collaborative Kyle Knierim, MD January 2017

2 What is cardiovascular disease? Why are we even talking about cardiovascular disease? What can we do to prevent and treat cardiovascular disease? What can your practice do to improve systems of care for cardiovascular disease treatment and prevention?

3 Cardiovascular disease refers to a group of conditions affecting the heart (coronary heart disease and congestive heart failure) and blood vessels (stroke). CVD is the #1 killer in Colorado Preventing and treating CVD starts with healthy lifestyle choices Prevention and treating CVD also includes the ABCS: Aspirin use, Blood pressure control, Cholesterol control, and quitting Smoking That last question? It s up to you. That s why you re here!

4 Cardiovascular disease refers to a group of conditions affecting the heart (coronary heart disease and congestive heart failure) and blood vessels (stroke). Coronary Heart Disease Two Types Of Stroke

5

6 Heart Disease causes 1 in every 4 deaths in the US 1 Heart disease is the leading cause of death for both men and women 1 Americans have 735,000 heart attacks every year 2 1. CDC, NCHS. Underlying Cause of Death on CDC WONDER Online Database. Accessed via Access date: Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics 2015 update: a report from the American Heart Association. Circulation. 2015;131:e

7

8 CDPHE. Cardiovascular Disease Burden and Disparities in Colorado. Facts for Action: Chronic Diseases and Related Risk Factors in Colorado Source data taken from Colorado Behavioral Risk Factor Surveillance System.

9 Stroke is the fifth leading cause of death in the U.S. A stroke happens every 40 seconds and every 4 minutes someone dies from stroke. Up to 80 percent of strokes can be prevented. Stroke is the leading cause of adult disability in the U.S.

10 Heart Disease and Stroke Statistics 2015 Update. AHA/ASA.

11 That s $320,000,000,000 EVERY YEAR! Heart Disease and Stroke Statistics 2015 Update. AHA/ASA.

12

13 Two buckets: Non-modifiable things that won t change Modifiable things that can change (with effort)

14 NON-Modifiable risk factors to reduce your risk of cardiovascular disease Family History Age Ethnicity Gender Diabetes* Socioeconomic Status*

15 Modifiable risk factors to reduce your risk high blood pressure high cholesterol diabetes obesity physical inactivity of cardiovascular disease diets high in saturated fats, cholesterol, and sodium low fruit and vegetable consumption tobacco use exposure to secondhand smoke excessive alcohol use

16 Diet and exercise have a serious impact on CVD First line therapy for high blood pressure, high cholesterol, weight loss Saves lives in people who already had a heart attack* *Leon AS, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation. Jan

17 High intake of fruits, vegetables, and whole grains Lower intake of red meat Substitution of lower-fat or fat-free dairy products for higher-fat dairy foods Use of oils such as olive and canola, nuts, and margarines with flaxseed and/or rapeseed oil

18 Lyon Diet Heart Study 1 Mediterranean diet vs. typical US diet after first MI People eating Mediterranean diet had a 50% to 70% lower risk of recurrent heart disease measured by cardiac deaths and nonfatal heart attacks, unstable angina, stroke, heart failure, and pulmonary or peripheral embolism. International cohort study 2 Significantly reduced risk of CVD with an increased intake of vegetables, fruit, soy protein, and alcohol. CVD risk increased with a higher intake of meat.

19 All healthy adults age years need Moderate-intensity aerobic physical activity for a minimum of 30 min on five days each week OR Vigorous-intensity aerobic activity for a minimum of 20 min on three days each week. Moderate-intensity aerobic activity can be accumulated toward the 30-min minimum from bouts lasting 10 or more minutes Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. Aug ;116(9):

20 Those meeting basic activity guidelines had a 14% lower risk of CHD compared to individuals who had no leisurely time physical activity. People meeting the advanced guideline had a 20% lower risk As levels of physical activity increases, CVD risk decreases Even with activity below recommended levels people still saw CHD risk reduction benefits -- Something is better then nothing when it comes to exercise

21 Aspirin: Increase low-dose aspirin therapy according to recognized prevention guidelines Blood pressure: Prevent and control high blood pressure Cholesterol: Prevent and control high blood cholesterol Smoking: Increase tobacco screening, counseling services, and use of smoking cessation products CDC. Strategies for States to Address the ABCS of Heart Disease and Stroke Prevention Available from:

22 How does Aspirin prevent heart attacks and strokes? COX-1 inhibitor: Blocks the formation of thromboxane A2 in platelets Stops them from activating and clumping together

23 Aspirin prevents platelets from clumping in the middle of arteries

24 Clear cut for patients with known coronary artery disease: Long-term single antiplatelet therapy with aspirin 75 to 100 mg daily or clopidogrel 75 mg daily is recommended over no antiplatelet therapy Dual antiplatelet therapy (usually aspirin + another medication) is recommended in the first year after an acute coronary syndrome event. Suggested regimens vary based on the type of ACS intervention performed. Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. Feb 2012;141(2 Suppl):e637S-668S.

25 American College of Chest Physicians (ACCP): For persons aged 50 years or older consider low-dose aspirin 75 to 100 mg daily is recommended over no aspirin therapy United States Preventive Services Task Force (USPSTF): For men (45-79) and women (55-79) if potential reduction in risk of myocardial infarction outweighs potential harm to due gastrointestinal hemorrhage Ann Intern Med 2009 Mar 17;150(6):396 Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. Feb 2012;141(2 Suppl):e637S-668S.

26 American Heart Association (AHA): Persons with 10-year risk of cerebrovascular disease > 10% for cardiovascular prophylaxis (including but not limited to stroke) Persons with chronic kidney disease Women If BP is controlled and benefit for ischemic stroke and myocardial infarction prevention likely to outweigh risk of gastrointestinal bleeding and hemorrhagic stroke at dose 81 mg once daily or 100 mg every other day in women 65 years With diabetes mellitus unless contraindicated AHA 2011 evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2011 Mar 22;123(11):1243 AHA 2014 guidelines for primary prevention of stroke Stroke 2014 Dec;45(12):3754

27 A 2011 meta-analysis of nine primary prevention trials found that aspirin reduced the risk for total cardiovascular events and nonfatal heart attack, BUT did not reduce the risk of death from CHD, stroke, cardiovascular mortality, or death from any cause. In 2006 a meta-analysis was done on more than 40,000 men and 50,000 women, and there was a significant reduction in cardiovascular events in both groups with lowdose aspirin. Elwood P. Aspirin Revisited: Evaluating Aspirin's Role in Primary Prevention. Medscape Education Cardiology Accessed 7/5/15.

28 Aspirin: Increase low-dose aspirin therapy according to recognized prevention guidelines Blood pressure: Prevent and control high blood pressure Cholesterol: Prevent and control high blood cholesterol Smoking: Increase tobacco screening, counseling services, and use of smoking cessation products` CDC. Strategies for States to Address the ABCS of Heart Disease and Stroke Prevention Available from:

29 Systolic Diastolic Interpretation <130 <85 Normal High Normal Hypertension Stage Hypertension Stage II

30

31 Patient seated in calm environment with arm rested on support at level of heart Cuff size appropriate so bladder inside cuff encircles 80% of arm Use average of at least 2 measurements Measurement error Small number of readings Effects of recent activities Expense & Inconvenience White coat effect Proper Technique Common Issues

32 Home Blood Pressure Monitoring (HBPM) is better at predicting a person s risk of dying from heart disease or stroke than blood pressure measured in the doctor s office.

33 Two types: Primary (essential) 90-95% of patients have this type No identifiable underlying cause. Commonly treated with drugs in addition to lifestyle changes (e.g., exercise, proper nutrition, weight reduction, stress reduction). Secondary Caused by an identifiable underlying condition (i.e. renal artery disease, thyroid disease, pregnancy) Treat the underlying cause

34 Risk factor for: Dying early Coronary artery disease (CAD) Heart failure Chronic kidney disease Stroke Transient ischemic attack (TIA) Peripheral arterial disease (PAD) Mild cognitive impairment (MCI) Hypertension at age 50 years associated with about 5-year reduction in life expectancy 1 Difference of 10 mm Hg in systolic BP associated with increased risk of all-cause and cardiovascular-related mortality and morbidity 2 1. BMJ 2012 Mar 20;344:e Lancet 2002 Dec 14;360(9349):1903

35 Ages Diabetes Chronic kidney disease Ages 60+ without diabetes or chronic kidney disease

36 Always appropriate to include diet and exercise changes If diet and exercise changes will/do not work or if the initial BP >160/ use medications Approach Angiotensin Converting Enzyme Inhibitors Calcium Channel Blockers Diuretics Angiotensin Receptor Blockers Common Medications

37 Aspirin: Increase low-dose aspirin therapy according to recognized prevention guidelines Blood pressure: Prevent and control high blood pressure Cholesterol: Prevent and control high blood cholesterol Smoking: Increase tobacco screening, counseling services, and use of smoking cessation products` CDC. Strategies for States to Address the ABCS of Heart Disease and Stroke Prevention Available from:

38 Cholesterol Cholesterol is a waxy fat carried through the bloodstream by lipoproteins HDL High density lipoproteins Good cholesterol LDL Low density Lipoprotein Bad Cholesterol Good cholesterol (HDL) is stable and carries bad cholesterol (LDL) from the arteries. Bad cholesterol (LDL) sticks to artery walls and contributes to plaque build up

39

40 Diet and Exercise!!!!! Both for prevention and for treatment once it is high Diet is a bit confusing now because lowering the amount of cholesterol in your food does not seem to lower cholesterol your blood Statin medications

41 Clinical ASCVD LDL-C 190 mg/dl Diabetes Type 1 or 2 Age y 7.5% estimated 10-y ASCVD risk and age y Stone NJ, et al. Circulation. 2013: published online before print November 12, 2013.

42 ASCVD Statin Benefit Groups Heart healthy lifestyle habits are the foundation of ASCVD prevention. In individuals not receiving cholesterol-lowering drug therapy, recalculate estimated 10-y ASCVD risk every 4-6 y in individuals aged y without clinical ASCVD or diabetes and with LDL C mg/dl. Adults age >21 y and a candidate for statin therapy Yes Clinical ASCVD No Yes Yes Age 75 y High-intensity statin (Moderate-intensity statin if not candidate for high-intensity statin) Age >75 y OR if not candidate for high-intensity statin Moderate-intensity statin Definitions of High- and Moderate-Intensity Statin Therapy High Daily dose lowers LDL-C by approx. 50% Moderate Daily dose lowers LDL-C by approx. 30% to <50% LDL-C 190 mg/dl No Diabetes Type 1 or 2 Age y No Yes Yes High-intensity statin (Moderate-intensity statin if not candidate for high-intensity statin) Moderate-intensity statin Estimated 10-y ASCVD risk 7.5%* High-intensity statin Estimate 10-y ASCVD Risk with Pooled Cohort Equations* 7.5% estimated 10-y ASCVD risk and age y Yes Moderate-to-High Intensity Statin No ASCVD prevention benefit of statin therapy may be less clear in other groups In selected individuals, consider additional factors influencing ASCVD risk and potential ASCVD risk benefits and adverse effects, drug-drug interactions, and patient preferences for statin treatment Stone NJ, et al. Circulation. 2013: published online before print November 12, 2013.

43 statindecisionaid.mayoclinic.org

44 Statins Number Needed to Treat for 5 Years 10-Year Risk of CVD Events 5-Year NNT for CVD Events 5-Year NNT for MI 5-Year NNT for Stroke 5% * 7.5% * 5-Year NNT for Mortality 10% % % Adapted from Statins for prevention of cardiovascular disease. Dynamed. Accessed

45 Aspirin: Increase low-dose aspirin therapy according to recognized prevention guidelines Blood pressure: Prevent and control high blood pressure Cholesterol: Prevent and control high blood cholesterol Smoking: Increase tobacco screening, counseling services, and use of smoking cessation products` CDC. Strategies for States to Address the ABCS of Heart Disease and Stroke Prevention Available from:

46 Increases the risk of heart disease and heart attack. Nicotine raises blood pressure Carbon monoxide reduces the amount of oxygen that blood can carry. Exposure to other people's smoke can increase the risk of heart disease even for nonsmokers. Photos from: humansarefree.com/2012/02/smoking-kills-amazing-experiment-and.html

47 Smoking leads to disease and disability and harms nearly every organ of the body. 1 More than 16 million Americans are living with a disease caused by smoking. Smoking causes cancer, heart disease, stroke, lung diseases, diabetes, and chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis.

48 Worldwide, tobacco use causes nearly 6 million deaths per year 1 Cigarette smoking is responsible for one in five deaths annually, or 1,300 deaths every day 2 On average, smokers die 10 years earlier than nonsmokers 3

49 If smoking continues at the current rate among U.S. youth, 5.6 million of today s Americans younger than 18 years of age will die early This represents about one in every 13 Americans aged 17 years or younger who are alive today. Go here for more:

50 Cold turkey - Only about 4% to 7% of people are able to quit smoking on any given attempt without medicines or other help Medicines About 25% of smokers who use medicines can stay smoke-free for over 6 months Counseling Counseling and other types of emotional support can boost success rates higher than medicines alone

51 Combination of counseling and medication is more effective than either one alone and both should be offered.

52 Everything from 3 minute provider-led counseling to intensive 6 week programs work The more the better

53 Nicotine replacement therapy Patch, Gum, Lozenge, Inhaler, Nasal spray Bupropion Brand names are Zyban, Wellbutrin, or Aplenzin Varenicline Brand name Chantix

54

55 What is cardiovascular disease? Why are we even talking about cardiovascular disease? What can we do to prevent and treat cardiovascular disease? What can your practice do to improve systems of care for cardiovascular disease treatment and prevention?

56 Cardiovascular disease refers to a group of conditions affecting the heart (coronary heart disease and congestive heart failure) and blood vessels (stroke). CVD is the #1 killer in Colorado Preventing and treating CVD starts with healthy lifestyle choices Prevention and treating CVD also includes the ABCS: Aspirin use, Blood pressure control, Cholesterol control, and quitting Smoking

57

58

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life Your Guide to Ischemic What Happened to Me? You had a stroke. The stroke you had

More information

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν. Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic Stroke What happened to me? You had a stroke. The stroke

More information

Strokes , The Patient Education Institute, Inc. hp Last reviewed: 11/11/2017 1

Strokes , The Patient Education Institute, Inc.   hp Last reviewed: 11/11/2017 1 Strokes Introduction A stroke or a brain attack is a very serious condition that can result in death and significant disability. This disease is ranked as the third leading cause of death in the United

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Long-Term Complications of Diabetes Mellitus Macrovascular Complication Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates October/November 2015 By Daniel Kerner, PharmD A stroke occurs when blood flow to the brain is stopped or slowed, resulting in death or damage to brain cells. There are three main

More information

Heart disease and stroke major health problems

Heart disease and stroke major health problems Understanding Heart Disease Introduction We all know that heart health is important and that we should maintain a healthy diet and take regular exercise, but our hectic lifestyles don t always allow for

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

Steps Against Recurrent Stroke (STARS)

Steps Against Recurrent Stroke (STARS) Steps Against Recurrent Stroke (STARS) Take steps against recurrent stroke by making the necessary changes in your life. Your Guide to Ischemic What happened to me? You had a stroke. The stroke you had

More information

Heart Disease. Signs and Symptoms

Heart Disease. Signs and Symptoms Heart Disease The term "heart disease" refers to several types of heart conditions. The most common type is coronary artery disease, which can cause heart attack, angina, heart failure, and arrhythmias.

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313) University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

Stroke: Prevention is the Best Medicine

Stroke: Prevention is the Best Medicine Stroke: Prevention is the Best Medicine Donna Lindsay, MN, RN, CNS-BC, SCRN Neuroscience Clinical Nurse Specialist/ Stroke Program Coordinator Hennepin Stroke Center Stroke Statistics Approximately 795,000

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP What is Heart Disease Cardiovascular Disease (CVD): Heart or Blood vessels are not working properly. Most common reason

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center THE END! CHANGABLE Blood pressure Diabetes Mellitus Hyperlipidemia Atrial fibrillation Nicotine Drug abuse Life style NOT CHANGABLE

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

High Blood Cholesterol What you need to know

High Blood Cholesterol What you need to know National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

Coronary Artery Disease Clinical Practice Guidelines

Coronary Artery Disease Clinical Practice Guidelines Coronary Artery Disease Clinical Practice Guidelines Guidelines are systematically developed statements to assist patients and providers in choosing appropriate healthcare for specific clinical conditions.

More information

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Preventing Cardiovascular Disease Chapter 2 Cardiovascular Disease the leading cause of death in the U.S. 35.3% of all deaths

More information

Statins and Cholesterol. Noreen Devanney Primary Care Pharmacist Surrey Heath CCG

Statins and Cholesterol. Noreen Devanney Primary Care Pharmacist Surrey Heath CCG Statins and Cholesterol Noreen Devanney Primary Care Pharmacist Surrey Heath CCG What are Statins? Statins are drugs that lower cholesterol They act on the liver to decrease production Usually act within

More information

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered

More information

Cardiovascular Disease Risk Factors:

Cardiovascular Disease Risk Factors: Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood

More information

Heart Attack. PART 2. Health Issues of Special Interest to Women. Heart and Artery Diseases. Chapter 4

Heart Attack. PART 2. Health Issues of Special Interest to Women. Heart and Artery Diseases. Chapter 4 PART 2. Health Issues of Special Interest to Women Heart Attack Heart and Artery Diseases Chapter 4 You may not know that diseases of the heart and arteries (primarily heart attack, heart disease, high

More information

Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension)

Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension) Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension) Created by Dr. Maria-Carmen Adamuz, Consultant Cardiologist. Aug 2017. WHAT IS HYPERTENSION? Blood pressure (BP) is the

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

Control Your Risk Factors

Control Your Risk Factors Control Your Risk Factors The causes of CAD are called risk factors. Most risk factors are related to choices you make. Some risk factors you cannot control: family history, gender, and age. My Risk Factors

More information

Clinical Practice Guideline

Clinical Practice Guideline Clinical Practice Guideline Secondary Prevention for Patients with Coronary and Other Vascular Disease Since the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC)

More information

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide is based on the 2017 KP National Coronary Artery Disease

More information

Cardiovascular System and Health. Chapter 15

Cardiovascular System and Health. Chapter 15 Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Leading Causes of Death in US (2013-CDC):

Leading Causes of Death in US (2013-CDC): Leading Causes of Death in 1. Heart disease: 611,105 US (2013-CDC): 2. Cancer: 584,881 3. Chronic lower respiratory diseases (Emphysema and Chronic Bronchitis): 149,205 4. Accidents (unintentional injuries):

More information

SESSION 3 11 AM 12:30 PM

SESSION 3 11 AM 12:30 PM SESSION 3 11 AM 12:30 PM for the Primary Prevention of Cardiovascular Disease: A Personalized Approach SPEAKER Samia Mora MD, MHS Presenter Disclosure Information The following relationships exist related

More information

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only

More information

Women and Heart Disease

Women and Heart Disease Patient Education Women and Heart Disease Heart disease is the concern of every woman today. You might think that breast cancer and osteoporosis are the 2 biggest diseases that affect women. But, women

More information

CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES eissn Review Article

CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES eissn Review Article Review Article CARDIOVASCULAR DISORDERS: A MAJOR DEATH PROBLEM- IT S PREVENTION AND TREATMENTS N. K. Mishra 1 *, K.A. Chowdary 2, Gitanjali Mishra 3 1.Yalamarty Pharmacy College, YalamartyNagar, Tarluwada,

More information

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North

More information

OM s Health Corner Cholesterol & Heart Disease!!

OM s Health Corner Cholesterol & Heart Disease!! Cholesterol & Heart Disease!! We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces 75% of the cholesterol that circulates in our blood.

More information

Understanding Cholesterol and Triglycerides

Understanding Cholesterol and Triglycerides MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Cholesterol and Triglycerides About This Kit Along with cigarette smoking, high blood pressure, physical

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

Cholesterol Levels -- What They Mean, Diet and Treatment

Cholesterol Levels -- What They Mean, Diet and Treatment Cholesterol Levels -- What They Mean, Diet and Treatment What Is Cholesterol? We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

You have already begun to reduce your risk for heart attack and stroke just by reading this workbook. Instructions:

You have already begun to reduce your risk for heart attack and stroke just by reading this workbook. Instructions: You have already begun to reduce your risk for heart attack and stroke just by reading this workbook. You are in charge and can lead your team (your nurses, therapists, doctors, and family) in helping

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Because we care about your health

Because we care about your health Contact us For information on Trust services see www.awp.nhs.uk PALS To make a comment, raise a concern or make a complaint, please contact the Trust s Patient Advice and Liaison Service (PALS). Smoking

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

C-Reactive Protein and Your Heart

C-Reactive Protein and Your Heart C-Reactive Protein and Your Heart By: James L. Holly, MD Inflammation is the process by which the body responds to injury. Laboratory evidence and findings at autopsy studies suggest that the inflammatory

More information

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016 Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

How to Prevent Heart Disease

How to Prevent Heart Disease How to Prevent Heart Disease Introduction Heart disease is the leading cause of death worldwide. You can reduce your risk of heart disease with healthy habits. This reference summary explains heart disease

More information

Understanding Risk Factors for Stroke

Understanding Risk Factors for Stroke MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Risk Factors for Stroke About This Kit Risk factors have been identified that can predict who is most

More information

3/19/2015. Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula

3/19/2015. Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula Presenters Alice Teall MS, RN, FNP/PNP, FAANP Kate Gawlik, MS,

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from

More information

BOOK 3: LIVING SMOKE-FREE

BOOK 3: LIVING SMOKE-FREE BOOK 3: LIVING SMOKE-FREE Start reading this book on your Quit Day. The information in this book will help you stay smoke-free. Read through it over the next few days. It is divided into five sections.

More information

Hypertension. Risk Factors

Hypertension. Risk Factors Hypertension September 2016, ½ hour The National Institute of Health (NIH) estimates that about two-thirds of people in the United States over the age of 65 have high blood pressure, also known as hypertension.

More information

Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State

Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State Data Brief: Cardiovascular Diseases among American Indians and Alaska Natives in Washington State Prepared by IDEA-NW, a project of the Northwest Portland Area Indian Health Board Indian Leadership for

More information

Non communicable Diseases in Egypt and North Africa

Non communicable Diseases in Egypt and North Africa Non communicable Diseases in Egypt and North Africa Diaa Marzouk Prof. Community Medicine Faculty of Medicine, Ain Shams University Egypt 11 th March 2012 Level of Income North African countries according

More information

Health Promotion, Screening, & Early Detection

Health Promotion, Screening, & Early Detection OCN Test Content Outline 2018 Health Promotion, Screening, & Early Detection Kelley Blake MSN, RN, AOCNS, OCN UW Medicine/Valley Medical Center I. Care Continuum 19% A. Health promotion & disease prevention

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information

Prevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine

Prevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine Prevention of Heart Disease Giridhar Vedala, MD Cardiovascular Medicine What is Heart Disease? Heart : The most hard-working muscle of our body pumps 4-5 liters of blood every minute during rest Supplies

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Dyslipedemia New Guidelines

Dyslipedemia New Guidelines Dyslipedemia New Guidelines New ACC/AHA Prevention Guidelines on Blood Cholesterol November 12, 2013 Mohammed M Abd El Ghany Professor of Cardiology Cairo Universlty 1 1 0 Cholesterol Management Pharmacotherapy

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Prof. V.K.Gupta HOD CTVS Department Dr.RML Hospital & PGIMER

Prof. V.K.Gupta HOD CTVS Department Dr.RML Hospital & PGIMER Prof. V.K.Gupta HOD CTVS Department Dr.RML Hospital & PGIMER The Heart Video3 Coronary Arteries to heart Coronary Artery Disease Occurs when the coronary arteries that supply the heart muscle get blocked.

More information

Conflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important

Conflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important Aspirin, primary prevention and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; February 2017 Conflicts of Interest: None Primary prevention of ASCVD is important Myocardial Infarction Incidence

More information

Five chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Heart Disease (Coronary Artery Disease)

Heart Disease (Coronary Artery Disease) Heart Disease (Coronary Artery Disease) Understanding how the heart works To understand heart disease, you must first know how the heart works. The heart is like any other muscle, requiring blood to supply

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

Stroke Awareness. Presented by Jai Cho, MD Director of Stroke Unit Department of Neurology Kaiser Permanente, Santa Clara Medical Center.

Stroke Awareness. Presented by Jai Cho, MD Director of Stroke Unit Department of Neurology Kaiser Permanente, Santa Clara Medical Center. Stroke Awareness Presented by Jai Cho, MD Director of Stroke Unit Department of Neurology Kaiser Permanente, Santa Clara Medical Center May 5, 2009 FACTS: Strokes in the U.S. Third leading cause of death

More information

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides A N A C P S P E C I A L R E P O R T Understanding and Managing Your Triglycerides What are Triglycerides? Triglycerides are one of several types of fat in your body, and the most common of them all. Along

More information

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke

More information

Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union

Hypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union Hypertension and Heart Disease Weldon James, MD, Mercy Clinic Family Medicine, Union The Silent Killer High blood pressure, also known as HBP or hypertension, is a widely misunderstood medical condition

More information

Questions to ask your healthcare professional

Questions to ask your healthcare professional Prepare to quit Get ready! Talk to your healthcare professional about how to quit Set a date for quitting. Choose a date that is within the next 2 weeks and make a strong commitment to quit on that day

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.

More information

CLINICAL OUTCOME Vs SURROGATE MARKER

CLINICAL OUTCOME Vs SURROGATE MARKER CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical

More information

For instance, it can harden the arteries, decreasing the flow of blood and oxygen to the heart. This reduced flow can cause

For instance, it can harden the arteries, decreasing the flow of blood and oxygen to the heart. This reduced flow can cause High Blood Pressure Blood pressure is the force of blood against your artery walls as it circulates through your body. Blood pressure normally rises and falls throughout the day, but it can cause health

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information